Swidro Bronchialpastillen N, Lutschpastillen

7680691210013 CH-69121 Tabletten
Swidro Bronchialpastillen N, Lutschpastillen
Swidro Bronchialpastillen N, Lutschpastillen
Swidro Bronchialpastillen N, Lutschpastillen
1 / 3
google

Article details

Package size
36
Selling units
36
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/08/2023
Patient information leaflet
Français
07/08/2023
Patient information leaflet
Italien
07/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
3.1 MG Substance Wirkstoff (Principe actif)
(N/A)
1.4 MG Substance Wirkstoff (Principe actif)
(N/A)
3.9 MG Substance Wirkstoff (Principe actif)
(N/A)
1.4 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
129.6 MG Substance Wirkstoff (Principe actif)
(N/A)
716.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Tentan AG

4452 Itingen

Authorization information

Swissmedic authorization number
69121
Drug name
Swidro Bronchialpastillen N, Lutschpastillen
Galenic form
LUTT
ATC Code
R05FB02
Authorization status
Z
Authorization category
Category C
Dispensing category
E
First authorization
09/11/2022
Authorization expiration date
31/12/9999
IT Number
03.02.0.
Domain
Human medicine
Field of application
Bei Erkältungshusten

Package details

Description (FR)
SWIDRO pastilles bronches N bte 36 pce
Description (DE)
SWIDRO Bronchialpastillen N Ds 36 Stk
Market launch
09/11/2022
Narcotic (BTM)
No